Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Cash & Current Investments (2016 - 2026)

Rockwell Medical filings provide 16 years of Cash & Current Investments readings, the most recent being $25.0 million for Q4 2025.

  • On a quarterly basis, Cash & Current Investments rose 15.72% to $25.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $25.0 million, a 15.72% increase, with the full-year FY2025 number at $25.0 million, up 15.72% from a year prior.
  • Cash & Current Investments hit $25.0 million in Q4 2025 for Rockwell Medical, up from $23.7 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $46.1 million in Q1 2021 to a low of $8.6 million in Q1 2024.
  • Median Cash & Current Investments over the past 5 years was $20.0 million (2022), compared with a mean of $21.6 million.
  • Biggest five-year swings in Cash & Current Investments: tumbled 78.51% in 2022 and later surged 101.08% in 2025.
  • Rockwell Medical's Cash & Current Investments stood at $22.4 million in 2021, then fell by 4.22% to $21.5 million in 2022, then tumbled by 49.12% to $10.9 million in 2023, then soared by 97.55% to $21.6 million in 2024, then grew by 15.72% to $25.0 million in 2025.
  • The last three reported values for Cash & Current Investments were $25.0 million (Q4 2025), $23.7 million (Q3 2025), and $18.4 million (Q2 2025) per Business Quant data.